CD86 and neoplasm: Immunofluorescent staining of tumor tissues for the vascular marker CD31 and macrophage markers CD86 (M1) and CD206 (M2) confirmed that Liensinine treatment reduced tumor vascular density, decreased M2 macrophage infiltration, and increased M1 macrophage polarization (Fig. 6D and Figure S4E).